Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

The new hair loss treatment kit was safe and improved hair growth without any adverse effects.

Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some herbal therapies may help with skin conditions, but more research is needed to confirm their safety and effectiveness.

Zinc is effective for treating various skin conditions, including warts and acne.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.